• In the media
  • GSK and J&J lead in vaccines research – but p...
Media - published on 06 Mar 2017

GSK and J&J lead in vaccines research – but pricing still an issue

Andrew McConaghie writes about the Access to Vaccines Index for PharmaPhorum. He leads with the finding that GSK and Johnson & Johnson are leading R&D investment in vaccines, and the field is producing the first ever vaccines for conditions such as Ebola and a range of deadly bacterial infections.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.